Evidence of Different Profiles of Side Effects and Drug–Drug Interactions among the Quinolones _ The Pharmacokinetic Standpoint

Publisher： Karger

E-ISSN： 1421-9794|47|3|24-31

ISSN： 0009-3157

Source： Chemotherapy, Vol.47, Iss.3, 2001-09, pp. : 24-31

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Venetoclax (ABT-199) Might Act as a Perpetrator in Pharmacokinetic Drug–Drug Interactions

By Weiss Johanna   Gajek Thomas   Köhler Bruno Christian   Haefeli Walter Emil  

Pharmaceutics, Vol. 8, Iss. 1, 2016-02 ,pp. : 5-5

MDPI

Access to resources Recommend Favorite

Avoiding Drug-Drug Interactions

By  

Chemotherapy, Vol. 55, Iss. 4, 2009-05 ,pp. : 215-220

Karger

Access to resources Recommend Favorite

History of Quinolones and Their Side Effects

By  

Chemotherapy, Vol. 47, Iss. 3, 2001-09 ,pp. : 3-8

Karger

Access to resources Recommend Favorite

Prediction of Drug-Drug Interactions with Bupropion and Its Metabolites as CYP2D6 Inhibitors Using a Physiologically-Based Pharmacokinetic Model

By Xue Caifu   Zhang Xunjie   Cai Weimin  

Pharmaceutics, Vol. 10, Iss. 1, 2017-12 ,pp. : 1-1

MDPI

Access to resources Recommend Favorite

Detection of Potential Drug-Drug Interactions for Outpatients across Hospitals

By Yeh Yu-Ting   Hsu Min-Hui   Chen Chien-Yuan   Lo Yu-Sheng   Liu Chien-Tsai  

International Journal of Environmental Research and Public Health, Vol. 11, Iss. 2, 2014-01 ,pp. : 1369-1383

MDPI

Access to resources Recommend Favorite